Patient‐Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo‐Controlled, Double‐Blind and 32‐Week Open‐Label Study

Publisher： John Wiley & Sons Inc

E-ISSN： 1549-490x|23|1|16-24

ISSN： 1083-7159

Source： The Oncologist, Vol.23, Iss.1, 2018-01, pp. : 16-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

By Hovey Elizabeth   de Souza Paul   Marx Gavin   Parente Phillip   Rapke Tal   Hill Andrew   Bonaventura Antonino   Michele Antony   Craft Paul   Abdi Ehtesham   Lloyd Andrew  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1233-1242

Springer Publishing Company

Access to resources Recommend Favorite

Erythropoietin Treatment under Polychemotherapy in Patients with Gynecologic Malignancies: A Prospective, Randomized, Double-Blind Placebo-Controlled Multicenter Study

By Kurz C.   Marth C.   Windbichler G.   Lahousen M.   Medl M.   Vavra N.   Sevelda P.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 461-466

Elsevier

Access to resources Recommend Favorite

Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study

By                    

Biomedical Reports, Vol. 3, Iss. 3, 2015-01 ,pp. : 355-360

Science Publishers

Access to resources Recommend Favorite

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer

By Eatock M. M.   Tebbutt N. C.   Bampton C. L.   Strickland A. H.   Valladares-Ayerbes M.   Swieboda-Sadlej A.   Van Cutsem E.   Nanayakkara N.   Sun Y.-N.   Zhong Z. D.   Bass M. B.   Adewoye A. H.   Bodoky G.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 710-718

Oxford University Press

Access to resources Recommend Favorite

Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

By Kotasek D.   Steger G.   Faught W.   Underhill C.   Poulsen E.   Colowick A.B.   Rossi G.   Mackey J.   for the AranespTM 980291 Study Group  

European Journal of Cancer, Vol. 39, Iss. 14, 2003-09 ,pp. : 2026-2034

Elsevier

Access to resources Recommend Favorite